Exposure–response Analysis and Simulation of Lenvatinib Safety and Efficacy in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer

Cancer Chemotherapy and Pharmacology - Germany
doi 10.1007/s00280-018-3687-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC